Skip to main content

Table 4 A Other site clarification

From: Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014

Subsite

N

Percent

Esophagus

31

5.45

Stomach

79

13.88

Other GI (large bowel, rectal, anal)

313

55.01

Hepatobiliary

20

3.51

Pelvic/ peritoneal

7

1.23

Bladder

12

2.11

Renal/ureters

23

4.04

Prostate

13

2.28

Uterus and ovaries/vulva

14

2.46

Skin

4

0.7

Adrenal glands

1

0.18

Breast

5

0.88

Non lung mediastinal

47

8.26

Frequency Missing = 1436